Brief: Hemogenyx Pharmaceuticals Says Second Patient Treated With HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation
03/06/2025 07:22
June 3 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: HEMOGENYX PHARMACEUTICALS PLC - SECOND PATIENT TREATED WITH HG-CT-1 CAR-T THERAPY SUCCESSFULLY PASSES INITIAL SAFETY EVALUATION HEMOGENYX PHARMACEUTICALS PLC - TREATMENT MET INITIAL SAFETY CRITERIA WITH EARLY EFFICACY INDICATIONS Source text: ID:nRSC1126La Further company coverage: HEMO.L ((( Reuters.Briefs@thomsonreuters.com );))